Live feed
Filing
SC 13D/A
SC 13D/A0000902664-23-003750·Ambrx Biopharma Cayman, Inc.
Schedule 13D ownership disclosure
AMBRX BIOPHARMA INC
Security class unavailable · CUSIP: 02290A102
Event date: 2023-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 116,820,452
- Percent of class
- 27.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-003750
- Form type
- SC 13D/A
- Filer
- Ambrx Biopharma Cayman, Inc.
- CIK
- CIK 1836056
- Filed
- Jun 28, 2023
- Reporting period
- Jun 27, 2023
- Description
- Schedule 13D beneficial ownership